Webinar: Getting from R&D to IND - Pitfalls to avoid and how to succeed
The road to IND isn’t always easy. Balancing speed, risk, and future needs is a challenge. Join Paul Jorjorian, Vice President and General Manager, Thermo Fisher Scientific, to learn how you can take your molecule from discovery through to FiH trials, balancing risk and accelerated timelines while ensuring a stable foundation for future scale-up and commercialization.
Vice President and General Manager, Biologics
Thermo Fisher Scientific
As the VP of biologics at Thermo Fisher Scientific, Paul oversees global biologics drug substance manufacturing and development. In his career Paul has developed, transferred or manufactured over 75 biotherapeutic proteins at various clinical phases, including multiple commercial products. His experience includes business strategy development, operations management, technology transfer, process development, process characterization and process validation. Paul holds a B.S. in Chemical Engineering and Management from Purdue University, and a Masters in Chemical Engineering from Cornell University.
NOW AVAILABLE ON DEMAND
Register now for this webinar